The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.
Eiji Oki
No relevant relationships to disclose
Ryota Nakanishi
No relevant relationships to disclose
Koji Ando
No relevant relationships to disclose
Hiroshi Saeki
No relevant relationships to disclose
Takefumi Ohga
No relevant relationships to disclose
Yoshihiro Kakeji
No relevant relationships to disclose
Shunichi Tsujitani
No relevant relationships to disclose
Shunji Kohnoe
No relevant relationships to disclose
Yoshihiko Maehara
No relevant relationships to disclose